Seminars in Immunopathology

, Volume 34, Issue 1, pp 73–91

Sphingosine 1-phosphate in coagulation and inflammation

Review

DOI: 10.1007/s00281-011-0287-3

Cite this article as:
Obinata, H. & Hla, T. Semin Immunopathol (2012) 34: 73. doi:10.1007/s00281-011-0287-3

Abstract

Sphingosine 1-phosphate (S1P) is a lipid mediator produced from sphingomyelin by the sequential enzymatic actions of sphingomyelinase, ceramidase, and sphingosine kinase. Five subtypes of cell surface G-protein-coupled receptors, S1P1–5, mediate the actions of S1P in various organs systems, most notably cardiovascular, immune, and central nervous systems. S1P is enriched in blood and lymph but is present at much lower concentrations in interstitial fluids of tissues. This vascular S1P gradient is important for the regulation of trafficking of various immune cells. FTY720, which was recently approved for the treatment of relapsing-remitting multiple sclerosis, potently sequesters lymphocytes into lymph nodes by functionally antagonizing the activity of the S1P1 receptor. S1P also plays critical roles in the vascular barrier integrity, thereby regulating inflammation, tumor metastasis, angiogenesis, and atherosclerosis. Recent studies have also revealed the involvement of S1P signaling in coagulation and in tumor necrosis factor α-mediated signaling. This review highlights the importance of S1P signaling in these inflammatory processes as well as the contribution of each receptor subtype, which exhibits both cooperative and redundant functions.

Keywords

Sphingosine 1-phosphateG-protein-coupled receptorVascular barrier integrityImmune cell traffickingCoagulationInflammation

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Center for Vascular Biology, Department of Pathology and Laboratory Medicine, Weill Cornell Medical CollegeCornell UniversityNew YorkUSA